DRAFT- NOT FOR PUBLISHING YET
A Record-Breaking Convergence and a New Global Standard
The Male Breast Cancer Global Alliance (MBCGA) 2025 Medical Summit has now firmly established itself as one of the most influential global forums dedicated to male breast cancer education, advocacy, and clinical advancement. Held October 24–25, 2025, the Summit exceeded expectations on every front—attendance, reach, scientific depth, and emotional resonance—surpassing participation records from previous years and signaling a new era of momentum for the Alliance
Under the visionary leadership of Cheri Ambrose, Founder and CEO of MBCGA, the Summit convened an extraordinary roster of international clinicians, researchers, survivors, caregivers, and advocates. What unfolded over two days was not simply a conference, but a living demonstration of how education, collaboration, and human connection can accelerate progress in a disease long overshadowed by gender bias.
Where Science Met Humanity
The 2025 Summit featured a meticulously curated agenda addressing the most urgent and emerging frontiers in male breast cancer—from early access and precision diagnostics to survivorship, rehabilitation, mental health, and global equity
Opening sessions set a decisive tone. Naomi Litchfield of Bionical Emas underscored why early access to therapies is not a luxury but a lifeline. That message was carried forward by Jose Pablo Leone, who delivered critical updates on the ETHAN Clinical Trial, one of the most important research efforts focused exclusively on breast cancer in men.
Innovation at the Clinical Frontier
Among the Summit’s most talked-about sessions was Robert Bard, whose presentation on image-guided tumor treatment showcased how advanced imaging is reshaping precision oncology. His emphasis on targeting disease while preserving healthy tissue reinforced a central Summit theme: smarter care, not more aggressive care
The future of precision monitoring took center stage with Ben Park, whose presentation on circulating tumor DNA (ctDNA) was widely regarded as a cornerstone of the Summit. “Our ability now to de-escalate therapies based upon knowing who really has microscopic cancer cells left—and who doesn’t—is going to be game-changing,” Dr. Park stated, highlighting a paradigm shift that could spare patients unnecessary toxicity while accelerating cures
Care Beyond Treatment
The Summit’s power lay equally in its attention to life beyond protocols. Charlotte Bayala delivered a deeply moving session on grounding oneself amid uncertainty—drawing from her lived experience as a caregiver. Her message echoed a sentiment that resonated across chat feeds and post-event feedback: science heals bodies, but presence heals families .
Physical recovery and long-term resilience were masterfully addressed by Leslie Waltke, whose evidence-based rehabilitation strategies reframed survivorship as an active, lifelong process rather than a passive aftermath.
Equally impactful was Barbara Bartlik, who confronted the often-ignored emotional and psychological toll of male breast cancer. Her call to integrate psychiatric care into oncology settings was both sobering and galvanizing
A Global Perspective, A Shared Mission
Day two expanded the Summit’s lens internationally. Fatima Cardoso delivered a landmark address on advanced and metastatic male breast cancer, blending scientific rigor with a global advocacy perspective. Her remarks underscored the urgent need for equity in research funding, diagnostics, and access to care worldwide
Mentorship, survivorship, and palliative care were powerfully explored by leaders including Keeshia Jones and Don Dizon, whose reframing of palliative care as a pathway to thriving challenged long-standing misconceptions.
Sponsors, Partners, and a Growing Movement
The success of the 2025 Summit was amplified by the engagement of sponsors and institutional partners—including Pfizer, whose participation highlighted the role of real-world evidence in expanding treatment access for men with breast cancer.
While final attendance figures are pending, organizers confirm that participation exceeded all prior MBCGA summits—an unmistakable indicator of growing global engagement and trust in the Alliance’s mission.
A Defining Moment for MBCGA
As the final sessions closed, one truth was unmistakable: the 2025 MBCGA Medical Summit was not just successful—it was transformational. It validated years of advocacy, elevated underrepresented voices, and forged new pathways for collaboration across disciplines and borders.
In the words echoed throughout the Summit, education is not optional—it is survival. And in 2025, MBCGA proved that when the world comes together with purpose, progress follows.
